Study prompts new ideas on cancers' origins

December 16, 2017, Washington University School of Medicine
Graduate student Megan Radyk and Jason Mills, M.D., Ph.D., led a study revealing that although many cancer therapies target rapidly dividing stem cells, mature cells also seem to play a key role in initiating cancer, at least in forming precancerous lesions. Credit: Matt Miller

Rapidly dividing, yet aberrant stem cells are a major source of cancer. But a new study suggests that mature cells also play a key role in initiating cancer—a finding that could upend the way scientists think about the origin of the disease.

Researchers at Washington University School of Medicine in St. Louis have found that mature cells have the ability to revert back to behaving more like rapidly dividing stem cells. However, when old cells return to a stem cell-like status, they can carry with them all of the mutations that have accumulated to date, predisposing some of those cells to developing into precancerous lesions.

The new study is published online in the journal Gastroenterology.

"As scientists, we have focused a good deal of attention on understanding the role of stem cells in the development of cancers, but there hasn't been a focus on mature cells," said senior investigator Jason C. Mills, MD, PhD, a professor of medicine in the Division of Gastroenterology. "But it appears when mature cells return back into a rapidly dividing stem cell state, this creates problems that can lead to cancer."

The findings, in mice and in human stomach cells, also raise questions about how may evade treatment.

Most cancer therapies are aimed at halting cancer growth by stopping cells from rapidly dividing. Such treatments typically attack stem cells but would not necessarily prevent mature cells from reverting to stem cell-like status.

Cancer therapies often target cells that grow and divide rapidly, such as stem cells, but in studying how stomach cancers occur, researchers at Washington University School of Medicine in St. Louis found that even when the stomach can't make stem cells, other cells in the stomach can begin to divide and contribute to precancerous lesions. Credit: Washington University BioMed Radio
"Cancer therapies target stem cells because they divide a lot, but if mature cells are being recruited to treat injuries, then those therapies won't touch the real problem," said first author Megan Radyk, a graduate student in Mills' laboratory. "If cancer recurs, it may be because the therapy didn't hit key mature cells that take on stem cell-like behavior. That can lead to the development of and, potentially, cancer."

Studying mice with injuries to the lining of the stomach, the researchers blocked the animals' ability to call on stem cells for help in the stomach. They focused on the stomach both because Mills is co-director of Washington University's NIH-supported Digestive Disease Center and because the anatomy in the stomach makes it easier to distinguish stem cells from mature cells that perform specific tasks. Even without stem cells, the mice developed a precancerous condition because mature stomach cells reverted back to a stem cell state to heal the injury.

Analyzing tissue specimens from 10 people with stomach cancer, the researchers found evidence that those same mature cells in the stomach also had reverted to a stem cell-like state and had begun to change and divide rapidly.

The Mills lab is working now to identify drugs that may block the by preventing mature cells from proliferating and dividing.

"Knowing these cells are leading to increased cancer risk may allow us to find drugs to keep mature from starting to divide and multiply," Mills said. "That may be important in preventing not only in the and GI tract but throughout the body."

Explore further: Researchers find stomach cancer pathway doesn't work as previously thought

More information: Megan D. Radyk et al, Metaplastic Cells in the Stomach Arise, Independently of Stem Cells, via Dedifferentiation or Transdifferentiation of Chief Cells, Gastroenterology (2017). DOI: 10.1053/j.gastro.2017.11.278

Related Stories

Researchers find stomach cancer pathway doesn't work as previously thought

January 23, 2017
Conventional wisdom holds that the loss of cells that secrete acid in the stomach leads to a condition that eventually can develop into stomach cancer.

Team discovers stem cells in the esophagus

October 16, 2014
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. ...

Source of liver stem cells identified

August 5, 2015
Howard Hughes Medical Institute (HHMI) scientists have identified stem cells in the liver that give rise to functional liver cells. The work solves a long-standing mystery about the origin of new cells in the liver, which ...

Recommended for you

Why some cancers affect only young women

October 19, 2018
Among several forms of pancreatic cancer, one of them specifically affects women, often young. How is this possible, even though the pancreas is an organ with little exposure to sex hormones? This pancreatic cancer, known ...

Scientists to improve cancer treatment effectiveness

October 19, 2018
Together with researchers from the University of Nantes and the University of Reims Champagne-Ardenne in France, experts from the National Research Nuclear University MEPhI have recently developed a quantum dot-based microarray ...

Mutant cells colonize our tissues over our lifetime

October 18, 2018
By the time we reach middle age, more than half of the oesophagus in healthy people has been taken over by cells carrying mutations in cancer genes, scientists have uncovered. By studying normal oesophagus tissue, scientists ...

Study involving hundreds of patient samples may reveal new treatment options of leukemia

October 17, 2018
After more than five years and 672 patient samples, an OHSU research team has published the largest cancer dataset of its kind for a form of leukemia. The study, "Functional Genomic Landscape of Acute Myeloid Leukemia", published ...

A 150-year-old drug might improve radiation therapy for cancer

October 17, 2018
A drug first identified 150 years ago and used as a smooth-muscle relaxant might make tumors more sensitive to radiation therapy, according to a recent study led by researchers at The Ohio State University Comprehensive Cancer ...

Loss of protein p53 helps cancer cells multiply in 'unfavourable' conditions

October 17, 2018
Researchers have discovered a novel consequence of loss of the tumour protein p53 that promotes cancer development, according to new findings in eLife.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

mdarr
5 / 5 (3) Dec 16, 2017
But presumably the mature to stem transition is important for the healing process. So just blocking the transition will create other problems.
Also the mature to stem transition is being explored for all sorts of therapies in the heart and other organs that don't normally heal. What does this research say about the future of those therapies.
Sounds like we need to know a lot more about the healthy vs problematic stem cell issue.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.